Vaccine hesitancy
In strongly vaccine-hesitant adults, provision of information on collective benefits reduces hesitancy to a greater extent than information on personal benefit.
- True
- False
Immunology & Allergy
Pediatric Allergy Prevention
For infants at high risk of developing food allergies whose mothers cannot or choose not to breastfeed, hydrolyzed formulas are recommended to prevent food allergies.
- True
- False
Volume 37.3 - Question 7
Cytokine Storm
Which one of the following statements about cytokine storm is false?
- Nearly all patients are febrile.
- Neurologic toxic effects occur early.
- Many patients have hypertriglyceridemia.
- Patients can develop a stress-related or takosubo-like cardiomyopathy.
Volume 36.3 - Question 19
Monkeypox
Post-exposure prophylaxis with monkeypox vaccination for recently exposed persons is recommended.
- True
- False
Volume 38.2 - Question 27
Antihistamines for Allergic Rhinosinusitis
In the treatment of allergic rhinosinusitis, oral antihistamines combined with intranasal corticosteroids provide better symptom relief than intranasal corticosteroids alone.
- True
- False
Volume 38.1 - Question 11
Chronic Urticaria
Which one of the following statements about chronic urticaria is false?
- Most affected patients are men.
- There is usually no identifiable cause.
- A history of nonblanching lesions persisting for more than 24 hours that leave a residual bruise, suggests the alternative diagnosis of cutaneous vasculitis.
- Up to 30% of patients have cutaneous exacerbations provoked by the use of NSAIDS.
Volume 38.1 - Question 10
Volume 38.5 - Question 43
RSV Vaccination in Pregnancy
Which one of the following statements about vaccination in pregnancy to prevent respiratory syncytial virus (RSV) illness in infants is false?
- There is an increased risk of spontaneous abortion in subsequent pregnancies in vaccinated women.
- Serious adverse events are rare in the newborns of vaccinated women.
- It reduces the incidence of severe RSV-associated lower respiratory tract illness in infants within 90 days after birth.
- It is a single dose vaccine.